No Data
No Data
Express News | D. Boral Capital Maintains Buy on Anixa Biosciences, Maintains $10 Price Target
Sector Update: Health Care
Anixa Biosciences Shares Rise After Notice of Patent Allowance for Breast Cancer Vaccine
Express News | EXCLUSIVE: Anixa Biosciences Tells Benzinga 'Patent Broadens Immunogenic Compositions for Preventive Vaccine Approach'
Express News | EXCLUSIVE: Anixa Biosciences Tells Benzinga Co. Receives Notice Of Allowance From US Patent And Trademark Office For Patent Covering Breast Cancer Vaccine Technology
EXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent